CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 89 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $35,918,051 | +77.9% | 934,879 | +7.2% | 2.48% | +76.9% |
| Q1 2023 | $20,190,296 | +88260.2% | 872,151 | 0.0% | 1.40% | -46.8% |
| Q4 2022 | $22,850 | -99.9% | 872,151 | 0.0% | 2.63% | +39.0% |
| Q3 2022 | $17,146,000 | +12.4% | 872,151 | 0.0% | 1.89% | +23.6% |
| Q2 2022 | $15,254,000 | +6.9% | 872,151 | 0.0% | 1.53% | +55.8% |
| Q1 2022 | $14,268,000 | +0.3% | 872,151 | 0.0% | 0.98% | +14.6% |
| Q4 2021 | $14,225,000 | +27.8% | 872,151 | 0.0% | 0.86% | +71.6% |
| Q3 2021 | $11,129,000 | -9.6% | 872,151 | 0.0% | 0.50% | -6.2% |
| Q2 2021 | $12,315,000 | -34.3% | 872,151 | -27.7% | 0.53% | -19.1% |
| Q1 2021 | $18,745,000 | -2.0% | 1,206,266 | 0.0% | 0.66% | -22.8% |
| Q4 2020 | $19,131,000 | – | 1,206,266 | – | 0.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |